ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Thomas Shea
Programmatic Marketing

Anil Bhaskar
Unified Customer Experience

Bud Bilanich
Success Coach

Frank X. Powers
Healthcare Challenger Brands

Pat Purcell
Meeting Engagement

David Linetsky
Patient Activation

Stacey Gandler
Brand Nourishment

Laura Blair
Medication Adherence

Mike Viscel
Increasing Engagement

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement